Search results
These 2 No-Brainer Growth Stocks Are Breaking New Ground
Motley Fool via Yahoo Finance· 14 hours agoDrugmakers outside the biosimilar or generic-medicine market must constantly innovate to be...
One hour of social media a day doubles a child’s chance of smoking or vaping
Daily Telegraph· 3 hours agoDr Nick Hopkinson, professor of respiratory medicine at Imperial College and first author of the...
Q&A: Medical historians examine organization's silence over rise of Nazism
Phys.org· 4 hours agoIn December, the New England Journal of Medicine began a process of self-examination, publishing...
Israel Sending More Troops to Rafah Amid Warnings of Famine in Gaza
New York Times· 2 hours agoFighting in Rafah has closed off a vital border crossing in southern Gaza, forced hundreds of...
Loyola launches women's sports medicine program
Crain s Chicago Business· 7 hours agoLoyola Medicine has launched a women's sports medicine program, which it says is the first of its kind in the Chicago area. The program will provide an ...
Bill Gates Celebrates Daughter Jennifer's Graduation From Med School
E! News via Yahoo News· 4 hours agoJennifer Gates, the Microsoft founder's eldest daughter with ex-wife Melinda French Gates, graduated...
Citi raises Prime Medicine shares target on FDA Milestone By Investing.com
Investing.com· 16 hours agoOn Thursday, Citi upgraded Prime Medicine (NASDAQ:PRME) from Neutral to Buy, maintaining a shares...
Maker of weight loss drug Ozempic plans to study drug’s effects on alcohol consumption
WSMV Nashville· 7 hours agoThe feeling has been described by thousands of people taking medicines, which are in a class known...
Loyola Medicine Launches Pioneering Women's Sports | Newswise
Newswise· 20 hours agoMAYWOOD, IL – Loyola Medicine proudly announces the launch of its Women's Sports Medicine (WSM) program, a groundbreaking initiative dedicated exclusively ...
HC Wainwright Analysts Raise Earnings Estimates for Praxis Precision Medicines, Inc. (NASDAQ:PRAX)
ETF DAILY NEWS· 19 hours agoPraxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report) – Equities researchers at HC Wainwright raised their Q2 2024 EPS estimates for shares of Praxis Precision < ...
